Evonik Industries AG (FRA:EVK)
| Market Cap | 8.50B +36.6% |
| Revenue (ttm) | 14.55B +2.0% |
| Net Income | 174.00M +83.2% |
| EPS | 0.37 +80.8% |
| Shares Out | n/a |
| PE Ratio | 49.48 |
| Forward PE | 11.23 |
| Dividend | 1.00 (5.47%) |
| Ex-Dividend Date | Jun 4, 2026 |
| Volume | 34,432 |
| Open | 21.76 |
| Previous Close | 21.96 |
| Day's Range | 17.92 - 21.76 |
| 52-Week Range | 12.51 - 22.42 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 3, 2026 |
About Evonik Industries AG
Evonik Industries AG operates as a chemicals company in the Asia-Pacific, Europe, the Middle East, Africa, and the Americas. It operates through the Advanced Technologies, Custom Solutions, and Infrastructure segments. The Advanced Technologies segment provides polymers for medical applications; crosslinkers; hydrogen peroxide, a sterilizing agent for cleaning silicon wafers and a bleaching agent for the paper and textile industries; fumed and precipitated silicas and silanes for the automotive, tire, electronics, and cosmetics industries; and ... [Read more]
Financial Performance
In 2025, Evonik Industries AG's revenue was 14.07 billion, a decrease of -7.18% compared to the previous year's 15.16 billion. Earnings were 265.00 million, an increase of 19.37%.
Financial StatementsNews
German chemicals lobby lifts 2026 sales forecast, but warns recovery remains elusive
German chemicals lobby VCI on Thursday raised its 2026 industry sales forecast on the back of higher prices, but warned the temporary boost from supply disruptions tied to the Iran war had faded.
Evonik ‘cooling’ on potential bid for Ashland, Bloomberg reports
Evonik (EVKIF) executives plan to present new mid-term shareholder value targets to BASF (BASFY) during weekend discussions, following Evonik’s rejection of an improved takeover offer valuing the spec...
Evonik price target raised to EUR 15 from EUR 14 at JPMorgan
JPMorgan analyst Chetan Udeshi raised the firm’s price target on Evonik (EVKIF) to EUR 15 from EUR 14 and keeps an Underweight rating on the shares.
Evonik downgraded to Hold from Buy at DZ Bank
DZ Bank downgraded Evonik (EVKIF) to Hold from Buy with a EUR 22 price target
Evonik Industries AG Earnings Call Transcript: Q3 2026
Q3 adjusted EBITDA rose 40% to EUR 629 million, and 2026 earnings are expected in the upper half of guidance. ROCE guidance rose above 8%, with a ~11% target by 2029 and a stronger 2027 start expected.
Evonik Industries AG Quarterly report: Q3 2026
Evonik Industries AG has published its Q3 2026 quarterly earnings report on November 3, 2026.
Evonik Industries AG Slides: Q3 2026
Evonik Industries AG has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on November 3, 2026.
Evonik Industries AG Earnings release: Q3 2026
Evonik Industries AG released its Q3 2026 earnings on November 3, 2026, summarizing the period's financial results.
Evonik Q3 core profit misses estimates, sees earnings at upper end of guidance
German chemicals group Evonik posted third-quarter core profit slightly below analyst estimates on Tuesday, but said it expects full-year profitability to come in at the upper end of its guidance r...
Evonik Industries AG Slides: Company presentation
Evonik Industries AG has posted slides in relation to its latest quarterly earnings report, which was published on November 3, 2026.
Evonik: we are not ready to negotiate BASF's sweetened bid
German chemicals group Evonik, said on Friday that BASF's sweetened takeover offer was not enough to persuade it to start formal deal talks, but it has asked the suitor's management to elaborate on ...
Germany's RAG Foundation could sell entire Evonik stake
RAG Foundation, the largest shareholder in Evonik , could sell its entire stake in the German chemicals manufacturer, it said on Wednesday.
Evonik rejects BASF offer as too low, sources say
German chemicals maker Evonik has rejected a takeover offer of about €22.15 per share from larger peer BASF as too low, two people familiar with the matter told Reuters on Monday.
Evonik rejects BASF’s EUR 10.3B takeover bid, FT reports
A EUR 10.3B bid by BASF (BASFY) for Evonik (EVKIF) has been rejected as too low to warrant negotiations, setting up a potential takeover battle as Evonik pursues restructuring and…
Evonik rejects $11.7 billion BASF takeover bid, FT reports
Evonik has rejected a €10.3 billion ($11.7 billion) takeover bid from BASF for being too low to warrant formal negotiations or to allow its competitor to carry out due diligence, the Financ...
Chemicals Giant BASF Moves for Rival Evonik
The German company said it entered initial talks over a takeover of smaller peer Evonik, a tie-up that would bolster BASF's dominant position in Europe's chemicals industry.
BASF confirms ‘exploratory work’ for potential acquisition of Evonik
BASF (BASFY) confirms exploratory work with the RAG Foundation and Evonik Industries AG (EVKIF) on a possible acquisition of Evonik. Progress and outcome of the exploratory work is currently open.
Evonik confirms non-binding approach from BASF on potential takeover offer
Evonik (EVKIF) stated: “In response to recent media reports, the Executive Board of Evonik Industries AG confirms that it has received a non-binding approach from BASF (BASFY) SE regarding a…
BASF approaches Evonik about potential takeover, FT reports
BASF (BASFY) has approached Evonik (EVKIF) and its largest shareholder RAG-Stiftung about a potential merger, which could broaden BASF’s geographic and product footprint while accelerating consolidati...
Evonik downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley downgraded Evonik (EVKIF) to Equal Weight from Overweight with a price target of EUR 18, down from EUR 21. The firm cites animal nutrition “mean reversion risk” for…
Evonik price target raised to EUR 22 from EUR 20 at Citi
Citi raised the firm’s price target on Evonik (EVKIF) to EUR 22 from EUR 20 and keeps a Buy rating on the shares.
Evonik Industries AG Earnings Call Transcript: Q2 2026
Q2 2026 saw a 24% year-over-year rise in adjusted EBITDA to €630 million, driven by strong Advanced Technologies and methionine performance. Workforce reductions and portfolio optimization continue, with an upgraded full-year outlook and robust cash generation supporting guidance.
Evonik Industries AG Slides: Q2 2026
Evonik Industries AG has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 4, 2026.
Evonik Industries AG Quarterly report: Q2 2026
Evonik Industries AG has published its Q2 2026 quarterly earnings report on August 4, 2026.
Evonik Industries AG Earnings release: Q2 2026
Evonik Industries AG released its Q2 2026 earnings on August 4, 2026, summarizing the period's financial results.